The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Update on Fundamental Mechanisms of Thyroid Cancer
Open accessAbstract
The incidence of thyroid cancer (TC) has increased worldwide over the past four decades. TC is divided into three main histological types: differentiated (papillary and follicular TC), undifferentiated (poorly differentiated and anaplastic TC), and medullary TC, arising from thyroid C cells. This review discusses the molecular mechanisms associated to the pathogenesis of different types of TC and their clinical relevance. In the last years, progresses in the genetic characterization of TC have provided molecular markers for diagnosis, risk stratification and treatment targets. Recently, papillary thyroid cancer has been reclassified into two molecular subtypes, named BRAF-like and RAS-like, associated to different range of cancer risks. Similarly, the genetic characterization of follicular thyroid cancer has been proposed to complement the new histopathological classification in order to estimate the prognosis. New analyses characterized a comprehensive molecular profile of medullary thyroid cancer raising the role of RET mutations. More recent evidences suggested that immune microenvironment associated to TC may play a critical role in tumor invasion, with potential immunotherapeutic implications in advanced and metastatic TC. Several types of ancillary approaches have been developed to improve the diagnostic value of fine needle aspiration biopsies in indeterminate thyroid nodules. Finally, liquid biopsy, as non-invasive diagnostic tool for body fluids genotyping, brings a new prospective of disease and therapy monitoring. Despite all these novelties, much work still remains to be done to fully understand the pathogenesis and biological behaviors of the different types of TC and to transfer this knowledge in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Furthermore, the presence in some solid tumors of an intensive infiltration and the evidence of a contemporary antitumor response and a tolerant microenvironment, essential for tumor growth and progression, enforce the role of the immune system inside cancer (72).”
BackgroundIntegrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., Lee, N., Machens, A., Moley, J. F., Pacini, F., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0335 · Cited by 2,444
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
WHO Classification of Tumours of Endocrine Organs
김나래, Lloyd, Osamura, Rosai, & Klöppel, G. (2017) · Medical Entomology and Zoology · Cited by 1,600
Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510
Nikiforov, Y. E., Seethala, R. R., Tallini, G., Baloch, Z. W., Basolo, F., Thompson, L. D. R., Barletta, J. A., Wenig, B. M., Al Ghuzlan, A., Kakudo, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0386 · Cited by 1,404
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Landa, I., Ibrahimpasic, T., Boucai, L., Sinha, R., Knauf, J. A., Shah, R. H., Dogan, S., Ricarte-Filho, J. C., Krishnamoorthy, G. P., Xu, B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85271 · Cited by 1,284
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,042
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
Soares, P., Trovisco, V., Rocha, A. S., Lima, J., Castro, P., Preto, A., Máximo, V., Botelho, T., Seruca, R., & Sobrinho-Simões, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206706 · Cited by 679
Volante, M., Collini, P., Nikiforov, Y. E., Sakamoto, A., Kakudo, K., Katoh, R., Lloyd, R. V., LiVolsi, V. A., Papotti, M., Sobrinho-Simoes, M., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3180309e6a · Cited by 619
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
De Rubis, G., Rajeev Krishnan, S., & Bebawy, M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.006 · Cited by 535
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Pozdeyev, N., Gay, L. M., Sokol, E. S., Hartmaier, R., Deaver, K. E., Davis, S., French, J. D., Borre, P. V., LaBarbera, D. V., Tan, A.-C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0373 · Cited by 533
Adeniran, A. J., Zhu, Z., Gandhi, M., Steward, D. L., Fidler, J. P., Giordano, T. J., Biddinger, P. W., & Nikiforov, Y. E. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176432.73455.1b · Cited by 495
Evolving Understanding of the Epidemiology of Thyroid Cancer
Seib, C. D., & Sosa, J. A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.10.002 · Cited by 495
Steward, D. L., Carty, S. E., Sippel, R. S., Yang, S. P., Sosa, J. A., Sipos, J. A., Figge, J. J., Mandel, S., Haugen, B. R., Burman, K. D., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4616 · Cited by 486
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., Rabes, H. M., Fagin, J. A., & Nikiforov, Y. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523237 · Cited by 461
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
Fusco, A., Grieco, M., Santoro, M., Berlingieri, M. T., Pilotti, S., Pierotti, M. A., Porta, G. D., & Vecchio, G. (1987) · Nature · doi:10.1038/328170a0 · Cited by 413
Patel, K. N., Angell, T. E., Babiarz, J., Barth, N. M., Blevins, T., Duh, Q.-Y., Ghossein, R. A., Harrell, R. M., Huang, J., Kennedy, G. C., et al. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1153 · Cited by 393
An Overview of the Management of Papillary and Follicular Thyroid Carcinoma
MAZZAFERRI, E. L. (1999) · Thyroid · doi:10.1089/thy.1999.9.421 · Cited by 368
ras Mutations Are Associated With Aggressive Tumor Phenotypes and Poor Prognosis in Thyroid Cancer
Garcia-Rostan, G., Zhao, H., Camp, R. L., Pollan, M., Herrero, A., Pardo, J., Wu, R., Carcangiu, M. L., Costa, J., & Tallini, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.130 · Cited by 368
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
Kunstman, J. W., Juhlin, C. C., Goh, G., Brown, T. C., Stenman, A., Healy, J. M., Rubinstein, J. C., Choi, M., Kiss, N., Nelson-Williams, C., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu749 · Cited by 364
BRAF mutations are associated with some histological types of papillary thyroid carcinoma
Trovisco, V., Vieira de Castro, I., Soares, P., Máximo, V., Silva, P., Magalhães, J., Abrosimov, A., Guiu, X. M., & Sobrinho‐Simões, M. (2004) · The Journal of Pathology · doi:10.1002/path.1511 · Cited by 363
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
Romei, C., Ciampi, R., & Elisei, R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.11 · Cited by 352
PAX8-PPARγ Rearrangement in Thyroid Tumors: RT-PCR and Immunohistochemical Analyses
Nikiforova, M. N., Biddinger, P. W., Caudill, C. M., Kroll, T. G., & Nikiforov, Y. E. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200208000-00006 · Cited by 349
Yoo, S.-K., Lee, S., Kim, S.-J., Jee, H.-G., Kim, B.-A., Cho, H., Song, Y. S., Cho, S. W., Won, J.-K., Shin, J.-Y., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006239 · Cited by 349
Hiltzik, D., Carlson, D. L., Tuttle, R. M., Chuai, S., Ishill, N., Shaha, A., Shah, J. P., Singh, B., & Ghossein, R. A. (2006) · Cancer · doi:10.1002/cncr.21739 · Cited by 312
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up
Grogan, R. H., Kaplan, S. P., Cao, H., Weiss, R. E., DeGroot, L. J., Simon, C. A., Embia, O. M. A., Angelos, P., Kaplan, E. L., & Schechter, R. B. (2013) · Surgery · doi:10.1016/j.surg.2013.07.008 · Cited by 301
Development of the thyroid gland
Nilsson, M., & Fagman, H. (2017) · Development · doi:10.1242/dev.145615 · Cited by 286
Identifying patients with NTRK fusion cancer
Solomon, J. P., Benayed, R., Hechtman, J. F., & Ladanyi, M. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz384 · Cited by 270
Thyroid Cancer in the Pediatric Population
Paulson, V. A., Rudzinski, E. R., & Hawkins, D. S. (2019) · Genes · doi:10.3390/genes10090723 · Cited by 242
Ciampi, R., Romei, C., Ramone, T., Prete, A., Tacito, A., Cappagli, V., Bottici, V., Viola, D., Torregrossa, L., Ugolini, C., et al. (2019) · iScience · doi:10.1016/j.isci.2019.09.030 · Cited by 239
Self-citationMutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean Population
Kim, K. H., Kang, D. W., Kim, S. H., Seong, I. O., & Kang, D. Y. (2004) · Yonsei Medical Journal · doi:10.3349/ymj.2004.45.5.818 · Cited by 229
Zhu, Z., Ciampi, R., Nikiforova, M. N., Gandhi, M., & Nikiforov, Y. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1006 · Cited by 209
Cohen, Y., Rosenbaum, E., Clark, D. P., Zeiger, M. A., Umbricht, C. B., Tufano, R. P., Sidransky, D., & Westra, W. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0273 · Cited by 207
BRAF mutations in an Italian cohort of thyroid cancers
Fugazzola, L., Mannavola, D., Cirello, V., Vannucchi, G., Muzza, M., Vicentini, L., & Beck‐Peccoz, P. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02089.x · Cited by 184
Self-citationKnauf, J. A., Kuroda, H., Basu, S., & Fagin, J. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206602 · Cited by 181
Vuong, H. G., Altibi, A. M. A., Duong, U. N. P., & Hassell, L. A. (2017) · Clinical Endocrinology · doi:10.1111/cen.13413 · Cited by 154
Castinetti, F., Waguespack, S. G., Machens, A., Uchino, S., Hasse-Lazar, K., Sansó, G., Else, T., Dvořáková, Š., Qi, X. P., Elisei, R., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30336-x · Cited by 154
Frequent association between MEN 2A and cutaneous lichen amyloidosis
Verga, U., Fugazzola, L., Cambiaghi, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01782.x · Cited by 145
Pax-8–PPAR-γ fusion protein in thyroid carcinoma
Raman, P., & Koenig, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.115 · Cited by 144
The Primary Occurrence ofBRAFV600EIs a Rare Clonal Event in Papillary Thyroid Carcinoma
Guerra, A., Sapio, M. R., Marotta, V., Campanile, E., Rossi, S., Forno, I., Fugazzola, L., Budillon, A., Moccia, T., Fenzi, G., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0618 · Cited by 140
Fukahori, M., Yoshida, A., Hayashi, H., Yoshihara, M., Matsukuma, S., Sakuma, Y., Koizume, S., Okamoto, N., Kondo, T., Masuda, M., et al. (2012) · Thyroid · doi:10.1089/thy.2011.0261 · Cited by 137
Zhao, L., Dias-Santagata, D. C., Sadow, P. M., & Faquin, W. C. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21839 · Cited by 136
Concomitant RAS , RET/PTC , or BRAF Mutations in Advanced Stage of Papillary Thyroid Carcinoma
Zou, M., Baitei, E. Y., Alzahrani, A. S., BinHumaid, F. S., Alkhafaji, D., Al‐Rijjal, R. A., Meyer, B. F., & Shi, Y. (2014) · Thyroid · doi:10.1089/thy.2013.0610 · Cited by 126
GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland
Nikiforova, M. N., Nikitski, A. V., Panebianco, F., Kaya, C., Yip, L., Williams, M. D., Chiosea, S. I., Seethala, R. R., Roy, S., Condello, V., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0791 · Cited by 118
Clinical Course of Thyroid Carcinoma After Neck Dissection
Shah, M. D., Hall, F. T., Eski, S. J., Witterick, I., Walfish, P. G., & Freeman, J. L. (2003) · The Laryngoscope · doi:10.1097/00005537-200312000-00008 · Cited by 111
Zatelli, M. C., Trasforini, G., Leoni, S., Frigato, G., Buratto, M., Tagliati, F., Rossi, R., Cavazzini, L., Roti, E., & Uberti, E. C. D. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0353 · Cited by 111
MicroRNAs as Biomarkers in Thyroid Carcinoma
Celano, M., Rosignolo, F., Maggisano, V., Pecce, V., Iannone, M., Russo, D., & Bulotta, S. (2017) · International Journal of Genomics · doi:10.1155/2017/6496570 · Cited by 108
Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer
Xing, M. (2016) · BMC Medicine · doi:10.1186/s12916-016-0559-9 · Cited by 107
Elisei, R., Tacito, A., Ramone, T., Ciampi, R., Bottici, V., Cappagli, V., Viola, D., Matrone, A., Lorusso, L., Valerio, L., et al. (2019) · Genes · doi:10.3390/genes10090698 · Cited by 101
Self-citationNicolson, N. G., Murtha, T. D., Dong, W., Paulsson, J. O., Choi, J., Barbieri, A. L., Brown, T. C., Kunstman, J. W., Larsson, C., Prasad, M. L., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00277 · Cited by 96
Yang, J., Gong, Y., Yan, S., Chen, H., Qin, S., & Gong, R. (2019) · Endocrine · doi:10.1007/s12020-019-02117-2 · Cited by 96
Giannini, R., Moretti, S., Ugolini, C., Macerola, E., Menicali, E., Nucci, N., Morelli, S., Colella, R., Mandarano, M., Sidoni, A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01167 · Cited by 95
Self-citationRosignolo, F., Sponziello, M., Giacomelli, L., Russo, D., Pecce, V., Biffoni, M., Bellantone, R. D. A., Lombardi, C. P., Lamartina, L., Grani, G., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1032 · Cited by 91
Self-citationJung, S., Kim, M. S., Jung, C. K., Park, H.-C., Kim, S. Y., Liu, J., Bae, J. S., Lee, S. H., Kim, T., Lee, S. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11922 · Cited by 90
Kihana, T., Tsuda, H., Teshima, S., Nomoto, K., Tsugane, S., Sonoda, T., Matsuura, S., & Hirohashi, S. (1994) · Cancer · doi:10.1002/1097-0142(19940101)73:1<176::aid-cncr2820730130>3.0.co;2-t · Cited by 87
MicroRNA-based molecular classification of papillary thyroid carcinoma
Rosignolo, F., Memeo, L., Monzani, F., Colarossi, C., Pecce, V., Verrienti, A., Durante, C., Grani, G., Lamartina, L., Forte, S., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3960 · Cited by 87
Self-citationSandulache, V. C., Williams, M. D., Lai, S. Y., Lu, C., William, W. N., Busaidy, N. L., Cote, G. J., Singh, R. R., Luthra, R., & Cabanillas, M. E. (2016) · Thyroid · doi:10.1089/thy.2016.0076 · Cited by 84
Chua, E. L., Wu, W. M., Tran, K., McCarthy, S. W., Lauer, C. S., Dubourdieu, D., Packham, N. A., O’Brien, C. J., Turtle, J. R., & Dong, Q. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6722 · Cited by 57
Vuong, H. G., Kondo, T., Oishi, N., Nakazawa, T., Mochizuki, K., Inoue, T., Tahara, I., Kasai, K., Hirokawa, M., Tran, T. M., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.781 · Cited by 54
Antonello, Z. A., Hsu, N. Y.-H., Bhasin, M., Roti, G., Joshi, M., Hummelen, P. V., Ye, E., Lo, A. S., Karumanchi, S. A., Bryke, C. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21262 · Cited by 51
Romei, C., Tacito, A., Molinaro, E., Piaggi, P., Cappagli, V., Pieruzzi, L., Matrone, A., Viola, D., Agate, L., Torregrossa, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8470 · Cited by 51
Liquid Biopsy in Thyroid Cancer: New Insight.
Khatami, F., & Tavangar, S. M. (2018) · PubMed Central · Cited by 51
Boos, L. A., Dettmer, M. S., Schmitt, A. M., Rudolph, T. J., Steinert, H. C., Moch, H., Sobrinho-Simões, M. A., Komminoth, P., & Perren, A. A. (2013) · Histopathology · doi:10.1111/his.12150 · Cited by 44
Stokowy, T., Wojtaś, B., Jarząb, B., Krohn, K., Fredman, D., Dralle, H., Musholt, T. J., Hauptmann, S., Lange, D., Hegedűs, L. D., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1021-7 · Cited by 35
Smith, J. A., Read, M. L., Hoffman, J., Brown, R., Bradshaw, B., Campbell, C., Cole, T. R. P., Navas, J. D., Eatock, F., Gundara, J. S., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw057 · Cited by 33
Cunha, L. L., Morari, E. C., Guilhen, A. C. T., Razolli, D. S., Gerhard, R., Nonogaki, S., Soares, F. A., Vassallo, J., & Ward, L. S. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0285 · Cited by 32
Sarkar, S., Bailey, E., Go, Y. Y., Cook, R. F., Kalbfleisch, T., Eberth, J., Chelvarajan, R. L., Shuck, K. M., Artiushin, S., Timoney, P. J., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006467 · Cited by 32
Condello, V., Macerola, E., Ugolini, C., Napoli, L. D., Romei, C., Materazzi, G., Elisei, R., & Basolo, F. (2018) · Head & Neck · doi:10.1002/hed.25155 · Cited by 32
Chua, E. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2733 · Cited by 30
Finkel, A., Liba, L., Simon, E., Bick, T., Prinz, E., Sabo, E., Ben‐Izhak, O., & Hershkovitz, D. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4031 · Cited by 25
Cited by
Huang, J., Sun, W., Wang, Z., Lv, C., Zhang, T., Zhang, D., Dong, W., Shao, L., He, L., Ji, X., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02254-z · Cited by 198
“Moreover, occurrence and progression of PTC are affected by several factors such as genetic mutations, environmental exposure, and epigenetic alterations [6].”
Background
Metadata
- Authors
- Prete, A., Borges de Souza, P., Censi, S., Muzza, M., Nucci, N., & Sponziello, M.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2020-03-13
- Volume
- 11
- Pages
- 102-102
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3012017822
- Cited by
- 471
- References
- 81
- FWCI
- 36.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.